The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis

被引：0
|
作者：
Tice, Jeffrey A. [1 ]
Touchette, Daniel R. [2 ]
Lien, Pei-Wen [2 ]
Agboola, Foluso [3 ]
Nikitin, Dmitriy [3 ]
Pearson, Steven D. [3 ]
机构：
[1] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL USA
[3] ICER, Boston, MA USA
来源：
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY | 2022年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：119 / 124
页数：6
相关论文
共 50 条
  • [31] Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
    Howard, James F., Jr.
    Bril, Vera
    Burns, Ted M.
    Mantegazza, Renato
    Bilinska, Malgorzata
    Szczudlik, Andrzej
    Beydoun, Said
    De Rivera Garrido, Francisco Javier Rodriguez
    Piehl, Fredrik
    Rottoli, Mariarosa
    Van Damme, Philip
    Tuan Vu
    Evoli, Amelia
    Freimer, Miriam
    Mozaffar, Tahseen
    Ward, E. Sally
    Dreier, Torsten
    Ulrichts, Peter
    Verschueren, Katrien
    Guglietta, Antonio
    de Haard, Hans
    Leupin, Nicolas
    Verschuuren, Jan J. G. M.
    Claeys, Kristl
    Diez-Tejedor, Exuperio
    Mathew, Veena
    Sgarzi, Manlio
    Harvey, Brittany Leigh
    Farias, Jerrica
    Frangiomore, Rita
    Heintzman, Sarah
    de Meel, Robert
    Chopra, Manisha
    Alboini, Paolo Emilio
    Hietala, Albert
    Genge, Angela
    NEUROLOGY, 2019, 92 (23) : E2661 - E2673
  • [32] Eculizumab for the treatment of myasthenia gravis
    Mantegazza, Renato
    Cavalcante, Paola
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (09) : 991 - 998
  • [33] THE EFFECT OF OBESITY IN EFFICACY AND SAFETY IN THE ADAPT TRIAL OF EFGARTIGIMOD FOR GENERALIZED MYASTHENIA GRAVIS
    Pulley, Michael
    Pasnoor, Mamatha
    Gelinas, Deborah
    Brauer, Edward
    Kerstens, Rene
    Beydoun, Said
    Howard, James
    MUSCLE & NERVE, 2022, 66 : S105 - S105
  • [34] Eculizumab in myasthenia gravis: A review
    Zhou, Avery
    Ho, Sabrina
    Vickers, Aroucha
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2024, 38 (01) : 34 - 40
  • [35] MINIMAL SYMPTOM EXPRESSION IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS FROM TREATMENT WITH EFGARTIGIMOD
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Pasnoor, Mamatha
    Muppidi, Srikanth
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2021, 64 : S3 - S4
  • [36] POOR RESPONSE TO ECULIZUMAB IN PATIENTS WITH TREATMENT REFRACTORY GENERALIZED MYASTHENIA GRAVIS
    Katyal, Nakul
    Govindarajan, Raghav
    MUSCLE & NERVE, 2022, 66 : S13 - S13
  • [37] Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
    Muppidi, Srikanth
    Utsugisawa, Kimiaki
    Benatar, Michael
    Murai, Hiroyuki
    Barohn, Richard J.
    Illa, Isabel
    Jacob, Saiju
    Vissing, John
    Burns, Ted M.
    Kissel, John T.
    Nowak, Richard J.
    Andersen, Henning
    Casasnovas, Carlos
    de Bleecker, Jan L.
    Vu, Tuan H.
    Mantegazza, Renato
    O'Brien, Fanny L.
    Wang, Jing Jing
    Fujita, Kenji P.
    Howard, James F., Jr.
    Kaya, Angela
    Khursigara, Gus
    Armstrong, Roisin
    Diab, Diaa
    Capocelli, Kelley
    Lane, Cindy
    Sanders, Vicky
    Gandolfo, Ruth
    MUSCLE & NERVE, 2019, 60 (01) : 14 - 24
  • [38] Efgartigimod is safe and effective in myasthenia gravis with sepsis
    Thakre, Mona
    Hussein, Mohamed
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [39] Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience
    Antozzi, Carlo
    Frangiamore, Rita
    Rinaldi, Elena
    Vanoli, Fiammetta
    Andreetta, Francesca
    Grigoli, Eleonora Giacopuzzi
    Ciusani, Emilio
    Bonanno, Silvia
    Maggi, Lorenzo
    Mantegazza, Renato
    NEUROLOGICAL SCIENCES, 2025,
  • [40] Efgartigimod in AChR and non-AChR generalized myasthenia gravis: a single center experience
    Antozzi, C.
    Frangiamore, R.
    Rinaldi, E.
    Vanoli, F.
    Bonanno, S.
    Maggi, L.
    Mantegazza, R.
    NEUROMUSCULAR DISORDERS, 2024, 43
12345